Heart Doc VIP with Dr. Joel Kahn cover image

Episode 466: Breakthroughs in Heart Valve Disease Treatment

Heart Doc VIP with Dr. Joel Kahn

00:00

GLP-1 Drugs and Cardiovascular Benefits

Dr. Joel Kahn summarizes SELECT and a Lancet analysis showing semaglutide reduced cardiovascular events independent of weight loss.

Play episode from 04:42
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app